Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sharon Surrey Barbari Insider Profile
4 Followers
Sharon Surrey Barbari, EVP, Finance & CFO at Cytokinetics, holds 24.78K shares in Cytokinetics (Ticker: CYTK), holds ― shares in Foamix Pharma (Ticker: FOMX), holds 75.00K shares in VYNE Therapeutics (Ticker: VYNE).
Sharon Surrey Barbari Cytokinetics (CYTK)EVP, Finance & CFO
Cytokinetics (CYTK)
EVP, Finance & CFO
Ranked #47,209 out of 78,624 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-11.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Sharon Surrey Barbari holds in companies
Most Profitable Insider Trade
The most profitable trade made by Sharon Surrey Barbari
Sharon Surrey Barbari's Trading History
Cytokinetics
Mar 02, 2017
EVP, Finance & CFO
Uninformative Buy
―
$424.94K
Foamix Pharma
―
―
―
―
VYNE Therapeutics
Aug 21, 2020
Director
Informative Buy
111.00K
$129.00K
Agile Therapeutics
Jun 11, 2020
Director
Uninformative Buy
―
$73.39K
Sonoma Pharmaceuticals
Mar 02, 2018
Director
Uninformative Buy
―
$296.97K
List of latest transactions for each holding click on a transaction to see Sharon Surrey Barbari's performance on stock
You May Also Like
Sharon Surrey Barbari insider profile FAQ
What is the percentage of profitable transactions made by Sharon Surrey Barbari?
The percentage of profitable transactions made by Sharon Surrey Barbari is 50%.
What is the average return per transaction made by Sharon Surrey Barbari?
The average return per transaction made by Sharon Surrey Barbari is -11.20%.
What stocks does Sharon Surrey Barbari hold?
Sharon Surrey Barbari holds: CYTK, FOMX, VYNE, AGRX, SNOA stocks.
What was Sharon Surrey Barbari’s latest transaction?
Sharon Surrey Barbari latest transaction was an Uninformative Buy of ―.
What was Sharon Surrey Barbari's most profitable transaction?
Sharon Surrey Barbari’s most profitable transaction was an Informative Buy of VYNE stock on August 21, 2020. The return on the trade was 13.10%.
What is Sharon Surrey Barbari's role in Cytokinetics?
Sharon Surrey Barbari's role in Cytokinetics is EVP, Finance & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.